An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.

H LeCaer,P Fournel,H Jullian,C Chouaid,J Letreut,P Thomas,D Paillotin,M Perol,C Gimenez,A Vergnenegre

Critical Reviews in Oncology/Hematology（2007）

Cited 23|Views19

No score

Abstract

The aim of this study was to determine the impact of patient selection based on age, comorbidity and performance status on the efficacy of platinum-free combination therapy on non-small-cell lung cancer after 65 years of age.

Translated text

Key words

Chemotherapy,Comorbidity,Elderly,Lung cancer,Phase II trial

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined